These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
414 related articles for article (PubMed ID: 33557774)
21. LncRNA NEAT1 promotes cell proliferation, migration, and invasion via the miR-186-5p/PTP4A1 axis in cholangiocarcinoma. Li O; Jiang B; Yi WM; Zhang Y; Yang PZ; Guo C; Sun ZP; Peng C Kaohsiung J Med Sci; 2021 May; 37(5):379-391. PubMed ID: 33502823 [TBL] [Abstract][Full Text] [Related]
22. Long non-coding RNA MIR22HG inhibits cell proliferation and migration in cholangiocarcinoma by negatively regulating the Wnt/β-catenin signaling pathway. Hu X; Tan Z; Yang Y; Yang P J Gene Med; 2019 May; 21(5):e3085. PubMed ID: 30856284 [TBL] [Abstract][Full Text] [Related]
23. lncRNA CRNDE promotes the proliferation and metastasis by acting as sponge miR-539-5p to regulate POU2F1 expression in HCC. Li Z; Wu G; Li J; Wang Y; Ju X; Jiang W BMC Cancer; 2020 Apr; 20(1):282. PubMed ID: 32252678 [TBL] [Abstract][Full Text] [Related]
24. Antitumor activity of celastrol by inhibition of proliferation, invasion, and migration in cholangiocarcinoma via PTEN/PI3K/Akt pathway. Zhu B; Wei Y Cancer Med; 2020 Jan; 9(2):783-796. PubMed ID: 31957323 [TBL] [Abstract][Full Text] [Related]
25. miR-122-5p Inhibits the Proliferation, Invasion and Growth of Bile Duct Carcinoma Cells by Targeting ALDOA. Xu Z; Liu G; Zhang M; Zhang Z; Jia Y; Peng L; Zhu Y; Hu J; Huang R; Sun X Cell Physiol Biochem; 2018; 48(6):2596-2606. PubMed ID: 30121648 [TBL] [Abstract][Full Text] [Related]
26. MicroRNA-144 suppresses cholangiocarcinoma cell proliferation and invasion through targeting platelet activating factor acetylhydrolase isoform 1b. Yang R; Chen Y; Tang C; Li H; Wang B; Yan Q; Hu J; Zou S BMC Cancer; 2014 Dec; 14():917. PubMed ID: 25479763 [TBL] [Abstract][Full Text] [Related]
27. MicroRNA-494-dependent WDHDI inhibition suppresses epithelial-mesenchymal transition, tumor growth and metastasis in cholangiocarcinoma. Liu B; Hu Y; Qin L; Peng XB; Huang YX Dig Liver Dis; 2019 Mar; 51(3):397-411. PubMed ID: 30314946 [TBL] [Abstract][Full Text] [Related]
28. LncRNA MT1JP functions as a ceRNA in regulating FBXW7 through competitively binding to miR-92a-3p in gastric cancer. Zhang G; Li S; Lu J; Ge Y; Wang Q; Ma G; Zhao Q; Wu D; Gong W; Du M; Chu H; Wang M; Zhang A; Zhang Z Mol Cancer; 2018 May; 17(1):87. PubMed ID: 29720189 [TBL] [Abstract][Full Text] [Related]
29. CyclinD1 inhibits dicer and crucial miRNA expression by chromatin modification to promote the progression of intrahepatic cholangiocarcinoma. Qi Y; Wang D; Huang W; Wang B; Huang D; Xiong F; Chen X; Chen Y J Exp Clin Cancer Res; 2019 Oct; 38(1):413. PubMed ID: 31590696 [TBL] [Abstract][Full Text] [Related]
30. lncRNA TMPO antisense RNA 1 promotes the malignancy of cholangiocarcinoma cells by regulating let-7g-5p/ high-mobility group A1 axis. Chang H; Yao Y Bioengineered; 2022 Feb; 13(2):2889-2901. PubMed ID: 35040749 [TBL] [Abstract][Full Text] [Related]
31. S100A11 promotes cell proliferation via P38/MAPK signaling pathway in intrahepatic cholangiocarcinoma. Zhang MX; Gan W; Jing CY; Zheng SS; Yi Y; Zhang J; Xu X; Lin JJ; Zhang BH; Qiu SJ Mol Carcinog; 2019 Jan; 58(1):19-30. PubMed ID: 30182496 [TBL] [Abstract][Full Text] [Related]
32. Long non-coding RNA PICSAR knockdown inhibits the progression of cutaneous squamous cell carcinoma by regulating miR-125b/YAP1 axis. Lu X; Gan Q; Gan C; Zheng Y; Cai B; Li X; Li D; Yin G Life Sci; 2021 Jun; 274():118303. PubMed ID: 32841663 [TBL] [Abstract][Full Text] [Related]
33. LncRNA SNHG16 promotes non-small cell lung cancer development through regulating EphA2 expression by sponging miR-520a-3p. Yu L; Chen D; Song J Thorac Cancer; 2020 Mar; 11(3):603-611. PubMed ID: 31953899 [TBL] [Abstract][Full Text] [Related]
34. SOX2 knockdown slows cholangiocarcinoma progression through inhibition of transcriptional activation of lncRNA PVT1. Yu A; Zhao L; Kang Q; Li J; Chen K; Fu H Biochem J; 2020 Sep; 477(18):3527-3540. PubMed ID: 32812642 [TBL] [Abstract][Full Text] [Related]
35. DSCAM-AS1 promotes tumor growth of breast cancer by reducing miR-204-5p and up-regulating RRM2. Liang WH; Li N; Yuan ZQ; Qian XL; Wang ZH Mol Carcinog; 2019 Apr; 58(4):461-473. PubMed ID: 30457164 [TBL] [Abstract][Full Text] [Related]
36. E2F1-induced upregulation of long non-coding RNA LMCD1-AS1 facilitates cholangiocarcinoma cell progression by regulating miR-345-5p/COL6A3 pathway. Yu J; Zhang B; Zhang H; Qi Y; Wang Y; Wang W; Wang Y; Wang Y Biochem Biophys Res Commun; 2019 Apr; 512(2):150-155. PubMed ID: 30876691 [TBL] [Abstract][Full Text] [Related]
37. Long non-coding RNA XIST promotes osteosarcoma progression by targeting YAP via miR-195-5p. Yang C; Wu K; Wang S; Wei G J Cell Biochem; 2018 Jul; 119(7):5646-5656. PubMed ID: 29384226 [TBL] [Abstract][Full Text] [Related]
38. Long Noncoding RNA NEAT1 Promotes Growth and Metastasis of Cholangiocarcinoma Cells. Zhang C; Li JY; Tian FZ; Zhao G; Hu H; Ma YF; Yang YL Oncol Res; 2018 Jul; 26(6):879-888. PubMed ID: 28810932 [TBL] [Abstract][Full Text] [Related]
39. Long non-coding RNA UCA1 promotes malignant phenotypes of renal cancer cells by modulating the miR-182-5p/DLL4 axis as a ceRNA. Wang W; Hu W; Wang Y; An Y; Song L; Shang P; Yue Z Mol Cancer; 2020 Jan; 19(1):18. PubMed ID: 31996265 [TBL] [Abstract][Full Text] [Related]
40. TUG1 knockdown inhibits the tumorigenesis and progression of prostate cancer by regulating microRNA-496/Wnt/β-catenin pathway. Li G; Yang J; Chong T; Huang Y; Liu Y; Li H Anticancer Drugs; 2020 Jul; 31(6):592-600. PubMed ID: 32427740 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]